1 |
Barrett AW, Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands: a valid prognostic indicator? Oral Oncol 2009;45:936-40.
DOI
ScienceOn
|
2 |
Waldron CA, el-Mofty SK, Gnepp DR. Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases. Oral Surg Oral Med Oral Pathol 1988;66:323-33.
DOI
ScienceOn
|
3 |
Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer 1978;42:265-82.
DOI
ScienceOn
|
4 |
Huang M, Ma D, Sun K, Yu G, Guo C, Gao F. Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 1997;26:435-9.
DOI
ScienceOn
|
5 |
Ellis GL, Auclair PL, Gnepp DR, editors. Surgical pathology of the salivary glands. Philadelphia: Saunders; 1991.
|
6 |
Barnes L, editor. Surgical pathology of the head and neck. 3rd ed. New York: Informa Healthcare; 2009.
|
7 |
Matsuba HM, Spector GJ, Thawley SE, Simpson JR, Mauney M, Pikul FJ. Adenoid cystic salivary gland carcinoma. A histopathologic review of treatment failure patterns. Cancer 1986;57:519-24.
DOI
ScienceOn
|
8 |
Allen MS Jr, Marsh WL Jr. Lymph node involvement by direct extension in adenoid cystic carcinoma. Absence of classic embolic lymph node metastasis. Cancer 1976;38:2017-21.
DOI
ScienceOn
|
9 |
Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984;54:1062-9.
DOI
ScienceOn
|
10 |
Hill ME, Constenla DO, A'Hern RP, et al. Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol 1997;33:275-8.
DOI
ScienceOn
|
11 |
Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Adenoid cystic carcinoma of the head and neck--a 20 years experience. Int J Oral Maxillofac Surg 2004;33:25-31.
DOI
ScienceOn
|
12 |
Gurney TA, Eisele DW, Weinberg V, Shin E, Lee N. Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation. Laryngoscope 2005;115:1278-82.
DOI
ScienceOn
|
13 |
Gomez DR, Hoppe BS, Wolden SL, et al. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys 2008;70:1365-72.
DOI
ScienceOn
|
14 |
Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 1995; 32:619-26.
DOI
ScienceOn
|
15 |
Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 2006;42:759-69.
DOI
ScienceOn
|
16 |
Alcedo JC, Fábrega JM, Arosemena JR, Urrutia A. Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Head Neck 2004;26:829-31.
DOI
ScienceOn
|
17 |
Hotte SJ, Winquist EW, Lamont E, et al. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 2005;23:585-90.
DOI
|
18 |
Evans PR, Gullane P, Montgomery P. Principles and practice of head and neck oncology. London: Martin Dunitz; 2002
|
19 |
Fauci AS, Braunwald E, Kasper DL, editors. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Medical; 2008.
|
20 |
Haddad R, Colevas AD, Tishler R, et al. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer 2003;97:412-8.
DOI
ScienceOn
|